GO:0001976 nervous system process involved in regulation of systemic arterial blood pressure: Neural Control of Blood Pressure, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001976 describes the neural regulation of systemic arterial blood pressure, a fast-acting homeostatic process mediated by the autonomic nervous system.
• The process integrates sensory detection (baroreceptors, chemoreceptors) with central processing in the brainstem and a rapid autonomic response.
• Key molecular players include ion channels (TRPA1), neurotransmitters, and signaling molecules that modulate sympathetic and parasympathetic outflow.
• Dysregulation of this process contributes to hypertension, orthostatic intolerance, and cardiovascular morbidity.
• Research models include genetic knockout, knock-in, and overexpression in rodents, as well as human physiological studies.
• CRISPR-based editing enables precise interrogation of genes involved in neural blood pressure control, accelerating target discovery.
Description
The regulation of systemic arterial blood pressure is a vital homeostatic function that ensures adequate perfusion of organs. While multiple systems contribute, the nervous system provides the fastest and most dynamic control, a process formally annotated as GO:0001976, nervous system process involved in regulation of systemic arterial blood pressure. This biological process encompasses the detection of blood pressure changes by sensory receptors, the integration of these signals within the central nervous system, and the generation of autonomic efferent responses that adjust heart rate, contractility, and vascular tone. Understanding this process is critical because its dysfunction underlies prevalent cardiovascular disorders such as hypertension and orthostatic hypotension. Moreover, the neural control of blood pressure interacts with other physiological systems, including cerebral blood flow regulation and metabolic homeostasis. Researchers studying this term aim to dissect the molecular and cellular mechanisms that govern rapid blood pressure adjustments, often using genetic and pharmacological tools. This article provides a comprehensive overview of GO:0001976, integrating authoritative definitions with insights from recent literature to guide experimental design and therapeutic targeting.
nervous system process involved in regulation of systemic arterial blood pressure At A Glance
| GO ID | GO:0001976 |
|---|---|
| GO term | nervous system process involved in regulation of systemic arterial blood pressure |
| Ontology | biological_process |
| Synonym | blood pressure regulation by neurological process; fast control of arterial pressure; neurological process involved in regulation of systemic arterial blood pressure; neurological system process involved in regulation of systemic arterial blood pressure |
| Major function | Neural detection and response to maintain systemic arterial blood pressure |
| Key anatomical sites | Brainstem (nucleus tractus solitarius, rostral ventrolateral medulla), baroreceptors, sympathetic and parasympathetic ganglia |
| Key neurotransmitters | Glutamate, GABA, acetylcholine, norepinephrine |
| Physiological outcome | Rapid adjustments in heart rate, vascular tone, and cardiac output |
What Is GO:0001976?
GO:0001976, nervous system process involved in regulation of systemic arterial blood pressure, is defined as the regulation of blood pressure mediated by detection of stimuli and a neurological response. In simpler terms, it is the fast, neural control of blood pressure that involves sensing changes and responding via the nervous system to maintain stable arterial pressure. This process is distinct from slower, hormonal or local mechanisms and is essential for moment-to-moment cardiovascular homeostasis.
Why Is nervous system process involved in regulation of systemic arterial blood pressure Important in Cell Biology?
GO:0001976 is critically important because it represents the primary rapid mechanism for blood pressure homeostasis. Dysfunction of this neural process is implicated in major cardiovascular diseases, including hypertension, orthostatic hypotension, and autonomic failure. The neural control of blood pressure also influences cerebral perfusion and is affected by conditions such as hypoxia. Understanding the molecular underpinnings of this process can reveal therapeutic targets for blood pressure disorders and improve outcomes in critical care settings.
• Maintains adequate organ perfusion during postural changes and stress.
• Dysregulation leads to hypertension, a leading risk factor for stroke and heart disease.
• Neural control is essential for cerebral blood flow autoregulation.
• Hypoxia alters sympathoexcitation, impacting blood pressure regulation.
• Provides targets for antihypertensive therapies acting on autonomic pathways.
• Involved in metabolic syndrome and obesity-related hypertension.
• Key for understanding orthostatic intolerance and syncope.
• Molecular components like TRPA1 channels modulate vascular tone.
• Exercise training can beneficially regulate microRNAs affecting this process.
• Genetic variations in autonomic genes influence blood pressure variability.
What Happens During nervous system process involved in regulation of systemic arterial blood pressure?
Sensory Detection of Blood Pressure Changes
In simple terms: Specialized sensors in blood vessels detect changes in pressure and send signals to the brain.
The process begins with baroreceptors located in the carotid sinus and aortic arch, which are stretch-sensitive mechanoreceptors that detect changes in arterial wall tension. Chemoreceptors in the carotid and aortic bodies also sense blood oxygen, carbon dioxide, and pH levels. These sensory afferents transmit signals via the glossopharyngeal (cranial nerve IX) and vagus (cranial nerve X) nerves to the central nervous system. The detection of stimuli is a key initial step, as defined by GO:0001976.
Central Integration in the Brainstem
In simple terms: The brainstem processes the sensory information and decides how to respond.
Sensory afferents synapse in the nucleus tractus solitarius (NTS) of the medulla oblongata. The NTS integrates excitatory and inhibitory inputs and projects to other brainstem nuclei, including the rostral ventrolateral medulla (RVLM) and the caudal ventrolateral medulla (CVLM). The RVLM is a major source of sympathetic premotor neurons, while the CVLM provides inhibitory modulation. Higher centers such as the hypothalamus and amygdala can also influence this integration. This central processing is crucial for generating an appropriate neurological response.
Autonomic Efferent Response
In simple terms: The brain sends commands through nerves to the heart and blood vessels to adjust blood pressure.
The integrated signal leads to changes in sympathetic and parasympathetic outflow. Increased sympathetic activity to the heart increases heart rate and contractility, while sympathetic vasoconstrictor fibers increase vascular resistance. Conversely, parasympathetic (vagal) activation slows heart rate. These efferent pathways release neurotransmitters such as norepinephrine and acetylcholine, which act on adrenergic and muscarinic receptors in target tissues. This rapid neural response is the hallmark of GO:0001976.
Effector Mechanisms and Feedback
In simple terms: The heart and blood vessels change their activity, and the sensors check if the pressure is back to normal.
Effector responses include modulation of cardiac output (via heart rate and stroke volume) and total peripheral resistance (via arteriolar tone). These changes are continuously monitored by baroreceptors, creating a negative feedback loop that maintains blood pressure within a narrow range. The process is also influenced by local factors such as endothelial function and circulating hormones, but the neural component provides the fastest correction. Dysregulation of this feedback can lead to chronic hypertension.
Key Genes Involved in GO:0001976 nervous system process involved in regulation of systemic arterial blood pressure
The following genes and proteins are integral to the nervous system process involved in regulation of systemic arterial blood pressure, based on their roles in sensory detection, central integration, and autonomic effector responses.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TRPA1 | Ion channel mediating sensory transduction in baroreceptors and vascular tone | Potential target for hypertension; studied in vascular smooth muscle |
| ADRB1 | Beta-1 adrenergic receptor mediating sympathetic effects on heart rate | Polymorphisms linked to blood pressure response; knockout models available |
| ADRB2 | Beta-2 adrenergic receptor mediating vasodilation and sympathetic effects | Target for asthma and hypertension; genetic variants affect receptor function |
| CHRNA3 | Nicotinic acetylcholine receptor subunit in autonomic ganglia | Associated with blood pressure regulation and smoking-related hypertension |
| GAD1 | Glutamate decarboxylase 1, synthesizes GABA | Involved in inhibitory neurotransmission in NTS; knockout affects baroreflex |
| GAD2 | Glutamate decarboxylase 2, synthesizes GABA | Similar to GAD1; important for central autonomic control |
| SLC6A2 | Norepinephrine transporter, reuptakes norepinephrine | Target of antihypertensives; mutations cause orthostatic intolerance |
| NOS1 | Neuronal nitric oxide synthase, produces NO | Modulates central sympathetic outflow; knockout mice show altered baroreflex |
| AGTR1 | Angiotensin II receptor type 1, mediates central angiotensin effects | Involved in central blood pressure regulation; target for ARBs |
| ACE | Angiotensin-converting enzyme, generates angiotensin II | Classic target for antihypertensives; affects central autonomic tone |
| P2RX2 | ATP-gated ion channel in sensory neurons | Mediates purinergic signaling in baroreceptors |
| SCN10A | Voltage-gated sodium channel Nav1.8 in sensory neurons | Mutations associated with cardiac conduction and blood pressure |
| KCNQ1 | Potassium channel involved in cardiac repolarization | Mutations cause long QT syndrome; affects blood pressure |
| RYR2 | Ryanodine receptor 2, calcium release in cardiac muscle | Mutations linked to arrhythmias and blood pressure dysregulation |
| NPPA | Atrial natriuretic peptide, promotes vasodilation and natriuresis | Biomarker for heart failure; interacts with neural control |
| NPPB | Brain natriuretic peptide, similar to NPPA | Biomarker for cardiac stress; affects blood pressure |
| EDN1 | Endothelin-1, potent vasoconstrictor | Involved in hypertension; regulated by neural activity |
| VEGFA | Vascular endothelial growth factor, affects vascular permeability and tone | Modulates cerebral blood flow during blood pressure changes |
How Is nervous system process involved in regulation of systemic arterial blood pressure Regulated?
The nervous system process involved in regulation of systemic arterial blood pressure is tightly regulated at multiple levels. At the molecular level, ion channels such as TRPA1 and voltage-gated sodium channels modulate sensory neuron excitability. Neurotransmitter release is controlled by presynaptic receptors and transporters like SLC6A2. Central integration is influenced by neuromodulators including nitric oxide (via NOS1) and angiotensin II (via AGTR1). Additionally, microRNAs and exercise-induced adaptations can regulate gene expression in autonomic pathways. Hypoxia can trigger sympathoexcitation, altering the set point of blood pressure regulation. These regulatory mechanisms ensure rapid and appropriate responses to physiological challenges.
nervous system process involved in regulation of systemic arterial blood pressure and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ADRB1 | Hypertension, heart failure | Knockout mouse; point mutation (e.g., Ser49Gly) |
| SLC6A2 | Orthostatic intolerance, depression | Knockout mouse; overexpression in sympathetic neurons |
| NOS1 | Hypertension, autonomic dysfunction | Knockout mouse; conditional knock-in |
| AGTR1 | Hypertension, cardiovascular remodeling | Knock-in mouse with humanized receptor; knockout |
| TRPA1 | Vascular tone dysregulation, pain | Knockout mouse; overexpression in sensory neurons |
Hypertension
Hypertension is a major disease linked to dysregulation of GO:0001976. Increased sympathetic outflow and impaired baroreflex sensitivity contribute to elevated blood pressure. Genetic variants in adrenergic receptors and ion channels can predispose individuals to hypertension. Targeting neural mechanisms is a key therapeutic strategy.
Orthostatic Hypotension
Orthostatic hypotension results from failure of the nervous system to adequately compensate for postural changes in blood pressure. This can be due to autonomic neuropathy or neurodegenerative disorders affecting central autonomic pathways. Studies using lower body negative pressure have provided insights into cerebral blood volume changes during such challenges.
Cardiovascular Mortality in Hypoxia
Chronic hypoxia, as seen in sleep apnea or high-altitude exposure, can lead to sustained sympathoexcitation and hypertension, increasing cardiovascular risk. The neural control of blood pressure becomes maladaptive, contributing to disease progression.
From nervous system process involved in regulation of systemic arterial blood pressure-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X affect baroreflex sensitivity? | Knockout mouse with telemetry blood pressure monitoring |
| Does a point mutation in gene Y alter autonomic tone? | Point-mutation knock-in mouse (e.g., CRISPR-engineered) |
| Can overexpression of gene Z rescue hypertension? | Transgenic overexpression mouse or viral vector delivery |
| What is the role of gene W in central integration? | Conditional knockout in brainstem nuclei (Cre-lox) |
| How does human variant V affect blood pressure regulation? | Humanized knock-in mouse or iPSC-derived neurons |
| Is gene U a therapeutic target for orthostatic hypotension? | Knockout rat; pharmacological challenge with tilt test |
How to Study the nervous system process involved in regulation of systemic arterial blood pressure Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Telemetry | Continuous blood pressure and heart rate | Long-term monitoring in conscious animals |
| Baroreflex sensitivity test | Heart rate response to blood pressure changes | Assessing autonomic function |
| CRISPR knockout | Gene function loss | Determining causality of candidate genes |
| RNA-seq | Transcriptomic changes | Identifying genes regulated in autonomic tissues |
| Proteomics | Protein expression and modifications | Discovering novel signaling molecules |
| Patch-clamp electrophysiology | Ion channel activity | Studying sensory neuron excitability |
| Functional MRI | Cerebral blood volume changes | Human studies of blood pressure regulation |
Telemetry Blood Pressure Monitoring
Implantable telemetry devices allow continuous, conscious blood pressure measurement in rodents, providing accurate assessment of neural control under physiological conditions. This method is essential for evaluating genetic models of GO:0001976.
Baroreflex Sensitivity Assessment
Baroreflex sensitivity can be assessed using pharmacological agents (e.g., phenylephrine and sodium nitroprusside) to induce blood pressure changes and measure heart rate responses. This quantifies the functional integrity of the neural process.
Genetic Manipulation and CRISPR Editing
CRISPR/Cas9 enables precise knockout, knock-in, or point mutations in genes involved in blood pressure regulation. These models help establish causality between specific genes and the neural process.
Neuroanatomical Tracing and Imaging
Viral tracing and immunohistochemistry can map neural circuits involved in blood pressure control. Functional MRI in humans can assess cerebral blood volume changes during blood pressure challenges.
How CRISPR Can Be Used to Study GO:0001976 nervous system process involved in regulation of systemic arterial blood pressure
Knockout
CRISPR knockout of genes such as ADRB1 or SLC6A2 in mice can reveal their essential roles in blood pressure regulation. These models are valuable for target validation and understanding disease mechanisms.
Point Mutation
Introducing point mutations (e.g., in SCN10A or KCNQ1) that mimic human variants allows study of their impact on neural control of blood pressure. This approach can uncover subtle functional changes not seen in knockouts.
Knock-in
Knock-in of humanized genes or reporter tags (e.g., GFP) enables visualization and functional analysis of specific cell types in autonomic pathways. This is useful for mapping circuits and studying gene expression dynamics.
Overexpression
Overexpression of candidate genes (e.g., NOS1 or VEGFA) using transgenic or viral approaches can test sufficiency in modulating blood pressure. This helps identify protective or detrimental effects.
How EDITGENE Supports nervous system process involved in regulation of systemic arterial blood pressure Research
Researchers studying nervous system process involved in regulation of systemic arterial blood pressure-related genes often need to determine whether a candidate gene is causally involved in the process or merely a biomarker. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell and animal models, enabling rigorous functional studies.
Contact EDITGENE today to design your custom CRISPR model for nervous system process involved in regulation of systemic arterial blood pressure research.
Frequently Asked Questions About nervous system process involved in regulation of systemic arterial blood pressure
What is GO:0001976?
GO:0001976 is a Gene Ontology term for the nervous system process involved in regulation of systemic arterial blood pressure, defined as the regulation of blood pressure mediated by detection of stimuli and a neurological response.
What genes are involved in nervous system process involved in regulation of systemic arterial blood pressure?
Key genes include ADRB1, ADRB2, SLC6A2, NOS1, AGTR1, ACE, TRPA1, and SCN10A, among others, which mediate sensory detection, central integration, and autonomic responses.
How does the nervous system regulate blood pressure?
The nervous system regulates blood pressure through baroreceptors and chemoreceptors that detect changes, brainstem nuclei that integrate signals, and autonomic efferents that adjust heart rate and vascular tone.
What diseases are associated with dysfunction of GO:0001976?
Dysfunction is linked to hypertension, orthostatic hypotension, autonomic failure, and increased cardiovascular risk in conditions like hypoxia.
What research models are used to study nervous system process involved in regulation of systemic arterial blood pressure?
Common models include knockout mice, knock-in mice with point mutations, transgenic overexpression, and human physiological studies using telemetry and functional MRI.
How can CRISPR help study blood pressure regulation?
CRISPR enables precise gene knockout, knock-in, and point mutations to test causality of candidate genes in neural blood pressure control.
What is the role of TRPA1 in blood pressure regulation?
TRPA1 is an ion channel in sensory neurons and vascular cells that contributes to detection of stimuli and modulation of vascular tone.
Can exercise affect the nervous system process involved in blood pressure regulation?
Yes, exercise training can alter microRNAs and other regulators, leading to beneficial effects on blood pressure and autonomic function.
What is the fast control of arterial pressure?
Fast control of arterial pressure is a synonym for GO:0001976, referring to the rapid neural mechanisms that adjust blood pressure moment-to-moment.
How does hypoxia affect blood pressure regulation?
Hypoxia can trigger sympathoexcitation, increasing sympathetic outflow and potentially leading to sustained hypertension.
Conclusion
GO:0001976, nervous system process involved in regulation of systemic arterial blood pressure, is a fundamental biological process that ensures rapid cardiovascular homeostasis. Its molecular dissection has revealed critical roles for ion channels, neurotransmitter transporters, and central signaling pathways. Dysregulation of this process contributes to prevalent diseases such as hypertension and orthostatic hypotension, making it a prime target for therapeutic intervention. Advances in CRISPR-based gene editing and physiological monitoring continue to deepen our understanding of this neural control system, offering hope for novel treatments.
References
- 1. Simpson LL et al.. 2024. Mechanisms underpinning sympathoexcitation in hypoxia.. J Physiol 602(21):5485-5503 PMID: 38533641
- 2. Reis DJ et al.. 1997. Autonomic and vasomotor regulation.. Int Rev Neurobiol 41:121-49 PMID: 9378586
- 3. Matić Z et al.. 2026. Neural mechanisms underlying blood pressure dynamics and cardiovascular control.. Am J Physiol Heart Circ Physiol 330(5):H1553-H1577 PMID: 41954137
- 4. Krukoff TL. 1998. Central regulation of autonomic function: no brakes?. Clin Exp Pharmacol Physiol 25(6):474-8 PMID: 9673828
- 5. Whittaker JR et al.. 2019. Changes in arterial cerebral blood volume during lower body negative pressure measured with MRI.. Neuroimage 187:166-175 PMID: 28668343
- 6. Earley S. 2012. TRPA1 channels in the vasculature.. Br J Pharmacol 167(1):13-22 PMID: 22563804
- 7. Postnov IuV. 2009. [Energy-dependent pathogenesis in chronic hypertension].. Arkh Patol 71(4):3-11 PMID: 19824421
- 8. Improta Caria AC et al.. 2018. Exercise Training-Induced Changes in MicroRNAs: Beneficial Regulatory Effects in Hypertension, Type 2 Diabetes, and Obesity.. Int J Mol Sci 19(11) PMID: 30445764
